A method for extraction and quantification of Ginkgo terpene trilactones

被引:17
作者
Ding, C
Chen, EQ [1 ]
Zhou, WJ
Lindsay, RC
机构
[1] Univ Wisconsin, Wisconsin Ctr Space Automat & Robot, Madison, WI 53711 USA
[2] Univ Wisconsin, Dept Food Sci, Madison, WI 53711 USA
关键词
D O I
10.1021/ac049809a
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A method was developed for the extraction and quantification of pharmacologically active terpene trilactones (ginkgolides, bilobalide) from the tissues of Ginkgo biloba L and pharmaceutical ginkgo products by RP-HPLC, based on the theory of terpene trilactones ionization. Four ginkgolides (GA, GB, GC, GJ) and bilobalide (BB) from both the ginkgo leaves and commercially available ginkgo extracts were quantitatively extracted by using this method. The recovery rate of the method was 97.5-100% with RSD of 1.2-2.8%. The detection limit was 0.05-0.1 mug, and the linear range was 0.1-12 mug. This detection limit represents a marked improvement over previously reported methods, suggesting the new method is a viable technique for routine analysis of ginkgo terpene trilactones in natural and commercial samples. The method reported by van Beek et al. in 1991 (van Beek, T. A.; Scheeren, H. A.; Rantio T.; Melger, W. C.; Lelyveld, G. P. J. Chromatogr. 1991, 543, 375-387.) was used as a reference method to monitor the accuracy of extraction and analysis in this study. SSI-MS technique was used to identify isolated target components. Carbohydrase treatment and solubility of terpene trilactones in various solvents were also discussed.
引用
收藏
页码:4332 / 4336
页数:5
相关论文
共 12 条
[1]  
BRAQUET P, 1988, GINKGOLIDES CHEM BIO, pR15
[2]   Ginkgo biloba extract:: Mechanisms and clinical indications [J].
Diamond, BJ ;
Shiflett, SC ;
Feiwel, N ;
Matheis, RJ ;
Noskin, O ;
Richards, JA ;
Schoenberger, NE .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2000, 81 (05) :668-678
[3]   An extraction method for determination of ginkgolides and bilobalide in ginkgo leaf extracts [J].
Lang, QY ;
Wai, CM .
ANALYTICAL CHEMISTRY, 1999, 71 (14) :2929-2933
[4]   Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761® in Alzheimer's disease [J].
Le Bars, PL ;
Velasco, FM ;
Ferguson, JM ;
Dessain, EC ;
Kieser, M ;
Hoerr, R .
NEUROPSYCHOBIOLOGY, 2002, 45 (01) :19-26
[5]   A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults:: neuropsychological findings [J].
Mix, JA ;
Crews, WD .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 (06) :267-277
[6]   Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761) [J].
Pietri, S ;
Maurelli, E ;
Drieu, K ;
Culcasi, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (02) :733-742
[7]  
SIEPRINA VS, 2003, AM FAM PHYSICIAN, V68, P923
[8]  
Strode JTB, 1996, J CHROMATOGR A, V738, P115
[9]   Comments on "An extraction method for determination of ginkgolides and bilobalide in Ginkgo leaf extracts" [J].
van Beek, TA .
ANALYTICAL CHEMISTRY, 2000, 72 (14) :3396-3396
[10]   Chemical analysis of Ginkgo biloba leaves and extracts [J].
van Beek, TA .
JOURNAL OF CHROMATOGRAPHY A, 2002, 967 (01) :21-55